Quantum Biopharma (QNTM) Receivables - Net (2018 - 2026)
Quantum Biopharma (QNTM) recorded Receivables - Net of $107,634 in Q2 2026, down 44.3% from $193,198 a year earlier and down 48.4% from the prior quarter.
Powered by 
Analysis
Quantum Biopharma (QNTM) Receivables - Net (2018 - 2026) Analysis & Trends
At the end of FY2025, Quantum Biopharma reported Receivables - Net of $231,053, down 38.3% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $374,678 in FY2024 (+63.8%), $228,764 in FY2023 (-38.9%), $374,377 in FY2022 (-25.3%) and $500,964 in FY2021 (+210.5%).
- Quarterly Receivables - Net has ranged from -$208,114 in Q3 2021 to $500,964 in Q4 2021 over the past five years.
- On a year-over-year basis, Receivables - Net has declined for four consecutive quarters, with an average decline of 3.3% over the last seven quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 210.5% in Q4 2021, against a decline of 62.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $208,524 (Q1 2026), $231,053 (Q4 2025) and $78,300 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Quantum Biopharma | 15.40 Mn | 3.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107,634.00 |
| Mar 31, 2026 | 208,524.00 |
| Dec 31, 2025 | 231,053.00 |
| Sep 30, 2025 | 78,300.00 |
| Jun 30, 2025 | 193,198.00 |
| Mar 31, 2025 | 393,843.00 |
| Dec 31, 2024 | 374,678.00 |
| Sep 30, 2024 | 104,204.00 |
| Jun 30, 2024 | 86,868.00 |
| Dec 31, 2023 | 228,764.00 |
| Sep 30, 2023 | 228,536.00 |
| Jun 30, 2023 | 230,839.00 |
| Mar 31, 2023 | 223,333.00 |
| Dec 31, 2022 | 374,377.00 |
| Dec 31, 2021 | 500,964.00 |
| Sep 30, 2021 | -208,114.00 |
| Jun 30, 2021 | -341,916.00 |
| Mar 31, 2021 | -52,894.00 |
| Dec 31, 2020 | 161,342.00 |
| Mar 31, 2020 | 1.45 Mn |
API Access
Quantum Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=QNTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "QNTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=QNTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();